-
$161 million! China Biopharmaceutical completes acquisition of F-star Therapeutics
The transaction will enable invoX to invest in and develop F-star's bispecific antibody platform as the backbone of future cancer immunotherapy.
2023-03-10 09:52 -
Cypress Biology: more than 100 million yuan of PreA round financing, accelerate the development o...
Recent progress in cypress biology.
2023-03-10 09:50 -
RSV vaccine $10 billion market Battle: Divided by 2023
Antigen selection is an important factor in determining the effectiveness of a vaccine.
2023-03-08 11:44 -
The chip maker went after the body parts
Hopefully, more and more crossover talent will emerge.
2023-03-08 11:40 -
ACS Med. Chem. Lett. | PROTAC targeted FLT3 - ITD proteins: new therapy of acute myeloid leukemia
A new treatment for acute myeloid leukemia!
2023-03-02 14:01 -
At present, many domestic enterprises have carried out differentiation transformation on allogeneic...
At present, many domestic enterprises have carried out differentiation transformation on allogeneic CAR-T to explore new ways out.
2023-03-02 13:57 -
What is the secret of vant Empire, which was founded eight years ago and has incubated more than 20 ...
Legendary company of legendary people
2023-03-02 13:55 -
For the first time, heparin was incorporated into the country, which ushered in a change in the ten-...
Will heparin domestic five male Pattern change?
2023-02-27 14:54 -
To accelerate the development of smart medical examination, Kingdomain Medical signed a strategic co...
Digital technologies will help promote the high-quality development of medical and health care.
2023-02-27 14:51 -
Hot News
- 关于进一步规范化学品信息发布、... Jan 27, 2026
- BASF’s 2025 Report Card—“Th... Jan 27, 2026
- Invista Reshuffles Global Nylo... Jan 28, 2026
- 5%–10% Is Just the Surface: B... Jan 15, 2026
- “Europe’s Chemical Industry ... Feb 02, 2026
Related Products
Related Producers
